Document is current
Any future updates will be listed below
-
Authors
Boulton, Andrew J. M. https://orcid.org/0000-0001-7856-1201
Jenkins, Alicia J. https://orcid.org/0000-0003-0583-3717
Makkar, Brij
Mankovsky, Boris https://orcid.org/0000-0001-8289-3604
Abera, Merhawit A. https://orcid.org/0000-0002-9755-5226
Tesfaye, Solomon https://orcid.org/0000-0003-1190-1472
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 7 January 2025
First Online: 15 April 2025
Acknowledgements
: The EASD organised a symposium at its 2023 Annual Meeting in Hamburg entitled ‘Facing the unexpected: how to fight diabetes while fighting the war or disaster’. The chair (AJMB) and two of the symposium speakers (BrM, BoM) are co-authors of this review.
: AJMB is the immediate Past-President of the IDF (2019–2022), Past-President of the EASD (2011–2015) and President of the Worldwide Initiative for Diabetes Education (2022–2025). He serves on the advisory boards for Nevro, AOT, Viatris and Wörwag. AJJ is the IDF-WPR Chair Elect, editor/author of the IDF-WPR Diabetes Care and Disasters guidelines (2nd edition), Chair of the IDF Disaster Committee and President of Insulin For Life Global; is a board member at Insulin for Life Australia; and collaborates with Life For a Child. She serves on the advisory boards for Abbott and GSK and lectures for CSL Seqirus. She has received research grants from Medtronic, Insulet, Ypsomed and Abbott/Viatris. BrM is the immediate Past-President of the Research Society for the Study of Diabetes in India (RSSDI) and Honorary Secretary of the AIAARO (Indian Obesity Society) (2023–2025). He serves on the advisory boards for or has received speaking fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi, Roche, LifeScan, Alembic, Alkem, Cipla, Torrent and USV. BoM is the President of the Ukrainian Diabetology Association. He has received advisory board and speaking fees from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Sanofi, Servier and Wörwag Pharma. ST has received consulting or speaker’s honoraria from Viatris, Nevro, Novo Nordisk, Merck, Grunenthal, P&G Health, Bayer, Wörwag Pharma, Angelini, Confo Therapeutics, AstraZeneca, NeuroPn and Merz. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.
: All authors were responsible for planning, drafting and revising the article and reviewing it critically for important intellectual content. All authors approved the version to be published.
